Skip to content

Biogen BIIB Other operating expenses

Other operating expenses at other companies

Rogers Corporation logo
Rogers CorporationROG
-$100K-150%
TG Therapeutics logo
TG TherapeuticsTGTX
$73.14M+89.0%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$60.19M+8.8%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$99.07M-4.6%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$57.31M+43.1%
Scholar Rock logo
Scholar RockSRRK
$102.02M+32.3%

Other financials

Income statement

See full
Revenue$2.5B+1.9%
Gross profit$1.8B+0.8%
Operating income$610.7M
Net income$319.5M+32.8%
EPS (diluted)$2.15+31.1%

Balance sheet

See full
Cash & equivalents$3.4B+30.2%
Total debt$6.6B+34.7%
Total equity$18.7B+9.9%
Total assets$29.5B+5.2%

Cash flow

See full
Operating cash flow$645.5M+149%
CapEx$51.2M+38.0%
Free cash flow$594.3M+167%

Valuation

See full
Market cap$31.9B+71.5%
Enterprise value$35.08B+56.4%
P/E22.5×+10.3×
P/S3.2×+1.3×

Profitability

See full
Gross margin75.5%-0.1pp
Operating margin22.9%
Net margin14.3%-0.8pp
FCF margin24.4%-0.4pp

Returns & leverage

See full
Return on equity8%-1.2pp
Debt / equity0.4×+0.1×
Current ratio3.1×+1.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biogen's other operating expenses?
Biogen (BIIB) reported other operating expenses of -$19.7M in Q1 2026.
How has Biogen's other operating expenses changed year-over-year?
Biogen's other operating expenses increased by 71.2% year-over-year, from -$68.4M to -$19.7M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.